Observational Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Oct 14, 2022; 28(38): 5636-5647
Published online Oct 14, 2022. doi: 10.3748/wjg.v28.i38.5636
Table 3 Results of indirect and direct markers of liver fibrosis together with hematological markers in examined patients
Parameter (reference range)
ALC
MAFLD
Controls
mean ± SD
Median
Min
Max
mean ± SD
Median
Min
Max
mean ± SD
Median
Min
Max
RDW (11%-15%)17.27 ± 3.2616.7d12.227.914.25 ± 2.5213.85a4.22513.45 ± 1.113.411.115
RPR0.26 ± 0.370.18d0.043.550.06 ± 0.020.06d0.020.180.05 ± 0.010.050.030.08
RLR19.14 ± 12.2715.73d1.679.2310.89 ± 8.558.13d0.66607.09 ± 2.486.243.3812.5
FIB-411.67 ± 25.466.34d0.69287.591.92 ± 1.631.57d0.2311.580.85 ± 0.540.710.283.27
GPR15.73 ± 28.546.65d0.18188.712.76 ± 5.570.54d0.1335.410.25 ± 0.10.240.060.63
PICP (ng/mL)63.32 ± 31.5360.536.15161.1252.14 ± 27.5646.0810.10147.2758.26 ± 37.3944.180202.89
PIIINP (ng/mL)9.28 ± 4.338.4b2.4328.6511.41 ± 3.9911.002.1825.3511.07 ± 5.6110.254.3543.63
PDGF-AB (pg/mL)18280.47 ± 8061.0617343.71c1925.6842823.8426858.68 ± 7335.0926682.8310821.0249808.0723579.28 ± 10068.825623.21638.247758.7
TGF-α (pg/mL)24 ± 45.3313.77d0.872507.0917.89 ± 19.1812.09d1.39142.6328.44 ± 17.2124.591.3193.55
Laminin (ng/mL)976.34 ± 705.29832.06a101.9333301.0048 ± 230.24375.23d72.871335.92718.24 ± 386.1663.27140.881813.88